In a recent study, researchers compared the efficacy of several epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of certain types of non-small cell lung cancer. READ MORE
Research in Review
Researchers conducted a study to see whether statin use before cancer diagnose could lead to improved survival in patients with non-small cell lung cancer.
A study of patients with inoperable NSCLC found that certain biomarkers may have prognostic value and enhance treatment decision-making.
A review of treatments for non-small cell lung cancer (NSCLC) that is epidermal growth factor receptor mutation positive (EGFR M+) has identified which therapies are the most effective at managing disease symptoms and progression.